Bausch + Lomb

Bausch + Lomb Responds to Rumors of a Potential Sale

Bausch + Lomb Corporation issued the following statement in response to a request from the Canadian Investment Regulatory Organization...

Read More
Soothe Dry Eye Therapy - from B+L

Bausch + Lomb Receives Health Canada Approval for Soothe® Antibiotic Drops

Bausch + Lomb Corporation announced Health Canada has approved Soothe Antibiotic Drops, an over-the-counter drop to treat external infections of the...

Read More
Bausch + Lomb

Bausch + Lomb Collects More Than 84 Million Units of Contact Lenses, Lens Care and Eye Care Materials Through Innovative Recycling Programs

Bausch + Lomb announced its ONE by ONE and Biotrue® Eye Care Recycling programs have collected 84,343,540 units, or...

Read More

Bausch Advances Novel Dry Eye Therapeutic to Phase 3

Quebec based B+L has announced the second of two Phase 3 studies studies evaluating the investigational treatment NOV03 (perfluorohexyloctane) as a...

Read More

US Ad Monitor Recommends B+L Discontinue Claims About PeroxiClear

Bausch + Lomb has voluntarily agreed to discontinue certain claims about PeroxiClear product, such as superior comfort over Clear Care, but was able...

Read More